Page last updated: 2024-10-31

neostigmine and Premature Birth

neostigmine has been researched along with Premature Birth in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"We compared miscarriages and preterm births within four weeks after surgery."1.91Fetal outcomes with and without the use of sugammadex in pregnant patients undergoing non-obstetric surgery: a multicenter retrospective study. ( Ishida, Y; Iwasaki, H; Kawasaki, Y; Mazda, Y; Noguchi, S; Ono Uokawa, R; Shiko, Y; Shinomiya, S, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Noguchi, S1
Iwasaki, H1
Shiko, Y1
Kawasaki, Y1
Ishida, Y1
Shinomiya, S1
Ono Uokawa, R1
Mazda, Y1

Other Studies

1 other study available for neostigmine and Premature Birth

ArticleYear
Fetal outcomes with and without the use of sugammadex in pregnant patients undergoing non-obstetric surgery: a multicenter retrospective study.
    International journal of obstetric anesthesia, 2023, Volume: 53

    Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Neostigmine; Pregnancy; Pregnancy Outcome; P

2023